
Valneva SE
VALNHealthcare|Biotechnology|FR
$5.51
-0.13 (-2.30%)
Tangible Book / Share
$0.63
Cash / Share
$1.28
Ownership Breakdown
90.1%
Float
95.1M
Shares Outstanding
85.7M
Float Shares
Major Holders (19)
Combined: 46.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Caisse des depots et consignations | Other | 9.30% | 19,074,653 | May 12, 2026 | 13D/G |
| Bpifrance S.A. | Other | 7.00% | 14,317,670 | May 12, 2026 | 13D/G |
| Bpifrance Participations S.A. | Other | 7.00% | 14,317,670 | May 12, 2026 | 13D/G |
| EPIC Bpifrance | Other | 7.00% | 14,317,670 | May 12, 2026 | 13D/G |
| Frazier Life Sciences Public Fund, L.P. | Partnership | 3.60% | 6,879,516 | May 12, 2026 | 13D/G |
| FHMLSP, L.P. | Partnership | 3.60% | 6,879,516 | May 12, 2026 | 13D/G |
| FHMLSP, L.L.C. | Other | 3.60% | 6,879,516 | May 12, 2026 | 13D/G |
| CDC Croissance S.A. | Other | 2.30% | 4,755,872 | May 12, 2026 | 13D/G |
| Frazier Life Sciences XII, L.P. | Partnership | 0.50% | 918,572 | May 12, 2026 | 13D/G |
| FHMLS Xii, L.P. | Partnership | 0.50% | 918,572 | May 12, 2026 | 13D/G |
| FHMLS Xii, L.L.C. | Other | 0.50% | 918,572 | May 12, 2026 | 13D/G |
| Frazier Life Sciences XI, L.P. | Partnership | 0.20% | 337,989 | May 12, 2026 | 13D/G |
| FHMLS XI, L.P. | Partnership | 0.20% | 337,989 | May 12, 2026 | 13D/G |
| FHMLS XI, L.L.C. | Other | 0.20% | 337,989 | May 12, 2026 | 13D/G |
| FHMLS X, L.L.C. | Other | 0.10% | 115,500 | May 12, 2026 | 13D/G |
| Patrick J. Heron | Individual | 0.10% | 115,500 | May 12, 2026 | 13D/G |
| James N. Topper | Individual | 0.10% | 115,500 | May 12, 2026 | 13D/G |
| Frazier Life Sciences X, L.P. | Partnership | 0.10% | 115,500 | May 12, 2026 | 13D/G |
| FHMLS X, L.P. | Partnership | 0.10% | 115,500 | May 12, 2026 | 13D/G |